218 related articles for article (PubMed ID: 15197982)
1. [Hyperviscosity syndrome, macroglobulinemia].
Hatta Y; Sawada U
Nihon Rinsho; 2004 May; 62 Suppl 5():550-3. PubMed ID: 15197982
[No Abstract] [Full Text] [Related]
2. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
3. A Puzzling Case of Hyperviscosity Syndrome.
Taher J; Chen C; Kulasingam V
J Appl Lab Med; 2020 Jan; 5(1):209-213. PubMed ID: 31662415
[No Abstract] [Full Text] [Related]
4. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
[TBL] [Abstract][Full Text] [Related]
5. Histidine based adsorbents for selective removal of monoclonal immunoglobulin IgM antibodies from Waldenstrom's macroglobulinemia patient sera: a preliminary study.
Srour M; Kassab I; Matta H; Elkak A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():1-5. PubMed ID: 23811496
[TBL] [Abstract][Full Text] [Related]
6. Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
Mullen EC; Wang M
Clin J Oncol Nurs; 2007 Feb; 11(1):87-95. PubMed ID: 17441400
[TBL] [Abstract][Full Text] [Related]
7. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests.
Beck JR; Quinn BM; Meier FA; Rawnsley HM
Transfusion; 1982; 22(1):51-3. PubMed ID: 6801828
[TBL] [Abstract][Full Text] [Related]
8. Waldenstrom's macrogloblinaemia: modified plasmapheresis as treatment option in a Nigeria setting.
Abjah UM; Aken'Ova YA; Ocheni S
Niger J Med; 2002; 11(4):190-2. PubMed ID: 12955999
[TBL] [Abstract][Full Text] [Related]
9. [Hyperviscosity syndrome and Waldenström's macroglobulinemia].
Shida M; Baba M; Sawada S
Nihon Rinsho; 1992 Jan; 50 Suppl():298-303. PubMed ID: 1578695
[No Abstract] [Full Text] [Related]
10. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal IgM rheumatoid factor in a patient with rheumatoid arthritis and hyperviscosity syndrome.
Rietveld AP; van Paassen HC
Neth J Med; 1983; 26(6):157-9. PubMed ID: 6412149
[No Abstract] [Full Text] [Related]
12. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
Menke MN; Feke GT; McMeel JW; Treon SP
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
[TBL] [Abstract][Full Text] [Related]
13. IV. Detection and differentiation of M-proteins by the acid-gel reaction--a re-evaluation.
Daniels JC; Cobb EK; Levin WC; Ritzmann SE
Tex Rep Biol Med; 1970; 28(4):541-5. PubMed ID: 4995465
[No Abstract] [Full Text] [Related]
14. Hyperviscosity retinopathy. A scientific approach to therapy.
Grindle CF; Buskard NA; Newman DL
Trans Ophthalmol Soc U K (1962); 1976 Jul; 96(2):216-9. PubMed ID: 827830
[No Abstract] [Full Text] [Related]
15. Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Buske C; Leblond V; Dimopoulos M; Kimby E; Jäger U; Dreyling M;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi155-9. PubMed ID: 24078658
[No Abstract] [Full Text] [Related]
16. Role of plasmapheresis in Waldenström's macroglobulinemia.
Stone MJ; Bogen SA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
[TBL] [Abstract][Full Text] [Related]
17. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
[No Abstract] [Full Text] [Related]
18. Plasmapheresis and cold sensitivity of immunoglobulin molecules. II. A study of macroglobulinemia polyclonalis spuria and immune complex disease.
Waldenström JG
Acta Med Scand; 1984; 216(5):467-74. PubMed ID: 6240922
[TBL] [Abstract][Full Text] [Related]
19. Hyperviscosity in plasma cell dyscrasias.
Kwaan HC
Clin Hemorheol Microcirc; 2013; 55(1):75-83. PubMed ID: 23455837
[TBL] [Abstract][Full Text] [Related]
20. Hyperviscosity syndrome in plasma cell dyscrasias.
Mehta J; Singhal S
Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
